Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1124-2025Class II

BD Pyxis MedStation Auxiliary 4000 REF: 306. Intended to securely store and dispense medications to a...

CareFusion 303, Inc / initiated 2024-02-23 / Open, Classified / root cause: design

CareFusion 303, Inc. began a recall of BD Pyxis MedStation Auxiliary 4000 REF: 306. Intended to securely store and dispense medications to a qualified and authorized healthcare provider on . FDA classified it as Class II and gives the reason as "Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-1124-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
CareFusion 303, Inc
Product
BD Pyxis MedStation Auxiliary 4000 REF: 306. Intended to securely store and dispense medications to a qualified and authorized healthcare provider.
Product code
BRY Cabinet, Table And Tray, Anesthesia
Reason for recall
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Root cause tag
design
FDA root cause
Device Design
Action
On February 14, 2023 and January 9. 2024 Carefusion issued a Urgent medical Device Product Advisory" Recall Notification to affected consignees. Carefusion asked consignees take the following actions: 1. Customers may continue to use these devices as intended and should file a complaint via the Customer Portal at https://www.bd.com/self-service or call BD Support at 1-800-727-6102, should you experience drawer or door failures. 2. If you experience delays in access to medication due to a drawer or door failure, ensure backup procedures (which may include but may not necessarily be limited to keys, emergency medication supplies, alternate devices in proximity, etc.) are in place and staff have all been properly trained on them. 3. Please promptly complete and return the enclosed Customer Response Form to acknowledge receipt of this notification and that you understand the information provided in this letter. 4. If you have specific questions about this letter, please contact 1-866-583-8783. 5. Any adverse health consequences experienced with the use of this product should be reported to BD and may be reported to the FDA s MedWatch Adverse Event Reporting Actions to be taken by distributor 1. Please provide a copy of this notification to any customers who may have received products listed in the Affected Products table above. 2. Please promptly complete and return the enclosed Customer Response Form to acknowledge receipt of this notification and that you understand the information provided in this letter.
Distribution
US: Nationwide OUS:JP IT IN DE GB KR NL TW ES BE AU BH CA BR NZ FR AR QA MX CL TR SA MY CH IL IE TH SG KW MA FI AE EG BS BM GR MC PL LB MO IQ TN NO PH CN HK CO JO OM
Product codes and lots
UDI: 10885403512636/ Serial Numbers: 16187325, 16187326, 16187327, 16173446

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1124-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1122-2025Class IIOngoingVoluntary: Firm initiated
Z-1123-2025Class IIOngoingVoluntary: Firm initiated
Z-1124-2025Class IIOngoingVoluntary: Firm initiated
Z-1125-2025Class IIOngoingVoluntary: Firm initiated